Trials / Completed
CompletedNCT03570060
Stepwise Screening for Silent Atrial Fibrillation After Stroke
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 264 (actual)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main hypothesis of this work is that an approach combining clinical parameters and biomarker assays could improve the understanding and prediction of the occurrence of silent atrial fibrillation (AF) in the acute phase after stroke. In this prospective work, the investigators will rely on the Dijon Stroke Registry, which collects extensive clinical data for each patient hospitalized for a stroke. As part of this registry, patients are seen 6 months after stroke to assess their clinical status. This clinical follow-up will allow us to judge the evolution of the AF diagnosed during the acute episode at a distance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Blood sample | 2 ml of blood for testing for serum biomarkers (IL-6, GDF-15, soluble ST-2 soluble, osteoprotegerin, galectin 3) |
| PROCEDURE | Long term ECG monitor | Fitting and removal of a long term ECG monitor (SpiderFlash, LivaNova) |
| PROCEDURE | Monitoring ECG | Recording of automatic ECG monitor results (CSM Philips IntelliVue MP50 system) |
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2023-03-23
- Completion
- 2023-03-23
- First posted
- 2018-06-26
- Last updated
- 2024-06-25
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03570060. Inclusion in this directory is not an endorsement.